Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)

CNY 14.39

(-0.41%)

Market Cap (In CNY)

12.86 Billion

Revenue (In CNY)

5.52 Billion

Net Income (In CNY)

1.03 Billion

Avg. Volume

9.32 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
11.83-24.57
PE
-
EPS
-
Beta Value
0.232
ISIN
CNE100001W36
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Yi Jiang Mei
Employee Count
-
Website
https://www.jiuzhoupharma.com
Ipo Date
2014-10-10
Details
Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.